Who is sponsoring NCT05101083?

NCT05101083 is sponsored by Starkey Laboratories, Inc.

What drugs are being tested in NCT05101083?

Interventions in NCT05101083: New Receiver-in-Canal Device, Legacy Receiver-in-Canal Device.

What condition does NCT05101083 study?

NCT05101083 studies Hearing Loss, Sensorineural, Hearing Loss.

Is NCT05101083 still recruiting?

NCT05101083 is currently completed. Last updated 18 January 2022.

Last reviewed 2022-01-18 · How we verify

NCT05101083

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Speech Intelligibility in Quiet and Noise for New vs. Legacy Hearing Aids

Completed NA Last updated 18 January 2022

What this trial tests

NA trial testing New Receiver-in-Canal Device in Hearing Loss, Sensorineural in 34 participants. Completed in 10 January 2022.

Timeline

25 October 2021

Primary endpoint
10 January 2022

10 January 2022

Quick facts

Lead sponsor	Starkey Laboratories, Inc
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	single
Primary purpose	treatment
Enrollment	34
Start date	25 October 2021
Primary completion	10 January 2022
Estimated completion	10 January 2022
Sites	1 location across United States

Drugs / interventions tested

New Receiver-in-Canal Device
Legacy Receiver-in-Canal Device

Conditions studied

Hearing Loss, Sensorineural — all drugs for Hearing Loss, Sensorineural →
Hearing Loss — all drugs for Hearing Loss →

Sponsor

Starkey Laboratories, Inc

Who can join

Adults 18 to 99, any sex, with Hearing Loss, Sensorineural or Hearing Loss. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This clinical investigation is designed to compare audiological performance (i.e., measurements of sound quality and speech understanding) between Starkey's new receiver-in-canal device and a commercially available legacy receiver-in-canal device.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Hearing Loss, Sensorineural

Currently open trials in the same condition.

NCT06499805 — Barriers and Facilitators to OTC Hearing Aids Success · NA · recruiting
NCT06560918 — Self-efficacy-based Auditory Rehabilitation With Over-the-Counter Hearing Aids · NA · recruiting
NCT06882889 — Comparing the Efficacy of Domestic Versus Imported Hearing Aids in ARHL · NA · recruiting
NCT06664697 — Post-Market Clinical Investigation of the IotaSOFT Insertion System · recruiting
NCT06268340 — Hearing and Structure Preservation Via ECochG · NA · recruiting

Other Starkey Laboratories, Inc trials

Trials by the same sponsor.

NCT05612763 — Self Fitting Hearing Aid Clinical Investigation · NA · completed
NCT04680871 — Validation of In-Ear Sensor · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05101083 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Starkey Laboratories, Inc
Last refreshed: 18 January 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05101083.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing